Drug application
NAFAZAIR (NAPHAZOLINE HYDROCHLORIDE)
Drugs@FDA ANDA 040073 · BAUSCH AND LOMB
Key facts
| Drug name | NAFAZAIR |
|---|---|
| Active ingredients | NAPHAZOLINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 040073 |
| Company | BAUSCH AND LOMB |
| Dosage forms | SOLUTION/DROPS, OPHTHALMIC |
| Strength | 0.1% |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | May 25, 1994 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.